| 10881608 |
Biodegradable intravitreal tyrosine kinase implants |
Patrick M. Hughes, Thomas C. Malone, Gerald W. DeVries, Joan-En Chang-Lin, Jane-Guo Shiah +3 more |
2021-01-05 |
| 10493082 |
4-pregenen-11β-17-21-triol-3,20-dione derivatives |
Alissar Nehme, Thomas C. Malone |
2019-12-03 |
| 10188667 |
Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives |
Alissar Nehme |
2019-01-29 |
| 10188665 |
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
Kelly M. Harrison |
2019-01-29 |
| 10076492 |
Biodegradable intravitreal tyrosine kinase implants |
Patrick M. Hughes, Thomas C. Malone, Gerald W. DeVries, Joan-En Chang-Lin, Jane-Guo Shiah +3 more |
2018-09-18 |
| 9820995 |
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
Kelly M. Harrison |
2017-11-21 |
| 9717743 |
Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives |
Alissar Nehme |
2017-08-01 |
| 9433631 |
4-pregenen-11β-17-21-triol-3,20-dione derivatives |
Alissar Nehme, Thomas C. Malone |
2016-09-06 |
| 9259429 |
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
Kelly M. Harrison |
2016-02-16 |
| 9233070 |
Biodegradable intravitreal tyrosine kinase implants |
Patrick M. Hughes, Thomas C. Malone, Gerald W. DeVries, Joan-En Chang-Lin, Jane-Guo Shiah +3 more |
2016-01-12 |
| 8969583 |
3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors |
Thomas C. Malone, C. Eugene Hull, III, Sougato Boral, Julie A. Wurster, Michael R. Robinson |
2015-03-03 |
| 8968766 |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
Patrick M. Hughes, Thomas C. Malone, Gerald W. DeVries, Joan-En Lin, Jane-Guo Shiah +1 more |
2015-03-03 |
| 8906892 |
4-pregenen-11β-17-21-triol-3,20-dione derivatives |
Alissar Nehme, Thomas C. Malone |
2014-12-09 |
| 8865691 |
Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21-triol-3,20-dione derivatives |
Alissar Nehme |
2014-10-21 |
| 8840872 |
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
Kelly M. Harrison |
2014-09-23 |
| 8512738 |
Biodegradable intravitreal tyrosine kinase implants |
Patrick M. Hughes, Thomas C. Malone, Gerald W. De Vries, Joan-En Chang-Lin, Jane-Guo Shiah +3 more |
2013-08-20 |
| 8455656 |
Kinase inhibitors |
Lon T. Spada, Jane-Guo Shiah, Patrick M. Hughes, Thomas C. Malone, Gerald W. DeVries +3 more |
2013-06-04 |
| 8383825 |
Kinase inhibitors |
Lon T. Spada, Jane-Guo Shiah, Patrick M. Hughes, Thomas C. Malone, Gerald W. DeVries +1 more |
2013-02-26 |
| 8143410 |
Kinase inhibitors |
Lon T. Spada, Jane-Guo Shiah, Patrick M. Hughes, Thomas C. Malone, Gerald W. DeVries +1 more |
2012-03-27 |
| 8062657 |
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
Kelly M. Harrison |
2011-11-22 |
| 7771742 |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
Patrick M. Hughes, Thomas C. Malone, Gerald W. De Vries, Joan-En Chang-Lin, Jane-Guo Shiah +1 more |
2010-08-10 |
| 7749530 |
Kinase inhibitors |
Lon T. Spada, Jane-Guo Shiah, Patrick M. Hughes, Thomas C. Malone, Gerald W. DeVries +2 more |
2010-07-06 |